HC Deb 17 October 2001 vol 372 cc1239-40W
Vernon Coaker

To ask the Secretary of State for Health what negotiations he plans to have with drug companies on the cost of beta interferon. [7427]

Mr. Hutton

[holding answer 15 October 2001]: We have met three companies in the light of the points made in the National Institute for Clinical Excellence's provisional appraisal determination and are planning further discussions.

Forward to